GlassScriptPhysician profile
Luis Cardenas
NPI 1093033482
$740.05
in general payments reported to CMS, 2019-2025
14 companies · $75.19 in 2025
The $75.19 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $96.27 · 2021: $82.14 · 2023: $101 · 2024: $149 · 2025: $75.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $130.14 | 2019 | |
| Edwards Lifesciences Corporation | $113.72 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $113.47 | 2021-2023 | Ultomiris |
| Biotissue Holdings INC. | $64.60 | 2024 | |
| Davol INC. | $63.40 | 2020 | |
| Smith+Nephew, INC. | $63.25 | 2019-2024 | Stravix |
| Solventum Corporation | $59.05 | 2024-2025 | Prevena, Abthera, V.A.C. Veraflo Cleanse Choice |
| E.R. Squibb & Sons, L.L.C. | $39.57 | 2020-2021 | |
| Teleflex LLC | $36.71 | 2025 | Quikclot |
| Convatec INC. | $16.67 | 2019 | |
| Becton, Dickinson and Company | $14.92 | 2024 | Hemosphere |
| Shire North American Group INC | $12.41 | 2019 | |
| Csl Behring | $12.14 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Cardenas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.